product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MITF (D5G7V) Rabbit mAb
catalog :
12590
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D5G7V
reactivity :
human, mouse
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 7
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; loading ...; fig 3d
He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 2
Alver T, Lavelle T, Longva A, Øy G, Hovig E, Bøe S. MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma. Oncotarget. 2016;7:55128-55140 pubmed publisher
  • western blot; human; 1:1000; fig 5
Talar B, Gajos Michniewicz A, Talar M, Chouaib S, Czyz M. Pentoxifylline Inhibits WNT Signalling in ?-Cateninhigh Patient-Derived Melanoma Cell Populations. PLoS ONE. 2016;11:e0158275 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 2d
Natale C, Duperret E, Zhang J, Sadeghi R, Dahal A, O Brien K, et al. Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors. elife. 2016;5: pubmed publisher
  • western blot; human; fig 3e
Moore A, Ceraudo E, Sher J, Guan Y, Shoushtari A, Chang M, et al. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat Genet. 2016;48:675-80 pubmed publisher
  • western blot; human; 1:2000; fig 4
Seip K, Fleten K, Barkovskaya A, Nygaard V, Haugen M, Engesæter B, et al. Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors. Oncotarget. 2016;7:19997-20015 pubmed publisher
  • western blot; human; 1:1000; fig 3c
Arts N, Cané S, Hennequart M, Lamy J, Bommer G, Van den Eynde B, et al. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS ONE. 2015;10:e0122517 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.